Mobile app version of munafa.co.com
Login or Join
 Learn then Earn
stockMarketNEWS

 story : Blueprint inks deal with Sixth Street, Royalty Pharma worth up to .2 billion #FinanceUSA #StockMarketNEWS Shares of Blueprint Medicines Corp. gained 3.3% in premarket trading on Thursday after

@stockMarketNEWS Fri 01 Jul, 2022

Posted in: #FinanceUSA #StockMarketNEWS

Blueprint inks deal with Sixth Street, Royalty Pharma worth up to .2 billion #FinanceUSA #StockMarketNEWS
Shares of Blueprint Medicines Corp. gained 3.3% in premarket trading on Thursday after the company announced a deal with investment firm Sixth Street and Royalty Pharma , which acquires pharmaceutical royalties, worth up to .2 billion. Sixth Street will pay 0 million upfront for future royalties for two products, up to 0 million in a senior secured credit facility, and 0 million in a potential credit facility to support any buy-side business opportunities. Royalty Pharma will pay 5 million for royalties for some sales of cancer-drug Gavreto, with up to 5 million in potential milestones. Blueprint's stock is down 51.2% this year, while the broader S&P 500 has declined 19.9%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme